July 15, 2024 New drug for stiff person syndrome granted designation to speed up development: ‘Thrilled for the community’ Kyverna Therapeutics’ new drug, KYV-101, has been designated by the U.S. Food and Drug Administration (FDA) a Regenerative Medicine Advanced Therapy (RMAT), the company announced on Monday.
July 15, 2024 Rare sleep disorder causes people to cook and eat food while they're asleep Sleep-related eating disorder (SRED) is a condition that causes people to eat and prepare food while sleeping. Experts Kara Becker and Kelly Baron discuss symptoms, risks and treatments.
July 11, 2024 Ozempic and other GLP-1 drugs could reduce arthritis symptoms in some, experts claim Some people with rheumatoid arthritis who use GLP-1 drugs — such as Wegovy and Ozempic — have reported an improvement in the severity and frequency of their arthritic symptoms. Two doctors weigh in.
July 11, 2024 In lupus breakthrough, researchers say they may have found what causes the autoimmune disease Researchers from Northwestern Medicine and Brigham and Women’s Hospital claim they have found a “molecular defect" that leads to lupus. Autoimmune experts weigh in on the potential impact.
July 10, 2024 Ozempic and Wegovy needles require proper disposal, health officials say — here's how to throw them away For those using medications like Ozempic and Wegovy, proper disposal is essential for safety. In certain areas, needles can be safely disposed of using household items.
July 9, 2024 Stiff person syndrome patients share what it’s like to live with the rare disease Two people who are living with stiff person syndrome — a rare neurological disorder that causes muscle rigidity and spasms — shared with Fox News Digital what their experience has been like.
July 7, 2024 New medications, caregiver stress relievers and epilepsy awareness top this week's health news This week's health roundup includes a new Alzheimer's medication, a man's fight for epilepsy awareness, tips for relieving caregiver stress, a summer COVID surge and more.
July 2, 2024 FDA approves new drug for Alzheimer’s disease: ‘Meaningful results’ The FDA has approved a new medication for people with Alzheimer’s disease. Eli Lilly’s Kisunla (donanemab) is a once-monthly injection intended for adults with early symptomatic Alzheimer's disease.
July 1, 2024 Mail-order ketamine injections can be ‘extremely dangerous,’ warns Dr. Marc Siegel Some mental health clinics are delivering ketamine injectable doses to their patients to administer at home. Fox News medical contributor Dr. Marc Siegel explains why this could be very risky.
June 30, 2024 Amid post-debate cognitive concerns, doctor recommends 3 natural supplements to boost brain power Dr. Nicole Saphier, associate professor at Memorial Sloan Kettering Cancer Center in New York City, shares recommendations for supplements to help improve mental focus and prevent dementia.